# Comparison of Alpha Blockers (Terazosin and Tamsulosin) in Reducing Ureteral Stent Related Symptoms

> **NCT06966804** · PHASE3 · RECRUITING · sponsor: **Penang Hospital, Malaysia** · enrollment: 150 (estimated)

## Conditions studied

- Stent Related Symptoms

## Interventions

- **DRUG:** Terazosin
- **DRUG:** Tamsulosin

## Key facts

- **NCT ID:** NCT06966804
- **Lead sponsor:** Penang Hospital, Malaysia
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06966804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06966804, "Comparison of Alpha Blockers (Terazosin and Tamsulosin) in Reducing Ureteral Stent Related Symptoms". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06966804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*